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Abstract 
 
Objectives: The aim of this study was to compare long-term outcomes of 
sandblasted and acid-etched (SLA) implants in patients previously treated for 
periodontitis and in periodontally healthy patients (PHP).  
Material and methods: One hundred and forty-nine partially edentulous 
patients were consecutively enrolled in private specialist practice and divided 
into three groups according to their periodontal condition: PHP, moderately 
periodontally compromised patients (PCP) and severely PCP. Implants were 
placed to support fixed prostheses, after successful completion of initial 
periodontal therapy. At the end of active periodontal treatment (APT), patients 
were asked to follow an individualized supportive periodontal therapy (SPT) 
program. Diagnosis and treatment of peri-implant biological complications 
were performed according to cumulative interceptive supportive therapy 
(CIST). At 10 years, clinical and radiographic measures were recorded by two 
calibrated operators, blind to the initial patient classification, on 123 patients, 
as 26 were lost to follow up. The number of sites treated according to therapy 
modalities C and D (antibiotics and/or surgery) during the 10 years was 
registered. 
Results: Six implants were removed for biological complications. The implant 
survival rate was 100% for PHP, 96.9% for moderate PCP and 97.1% for 
severe PCP. Antibiotic and/or surgical therapy was performed in 18.8% of 
cases in PHP, in 52.2% of cases in moderate PCP and in 66.7% cases in 
severe PCP, with a statistically significant differences between PHP and both 
PCP groups. At 10 years, the percentage of implants, with at least one site 
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that presented a PD ≥ 6 mm, was, respectively, 0% for PHP, 9.4% for 
moderate PCP and 10.8% for severe PCP, with a statistically significant 
difference between PHP and both PCP groups. 
Conclusion: This study shows that SLA implants, placed under a strict 
periodontal control, offer predictable long-term results. Nevertheless, patients 
with a history of periodontitis, who did not fully adhere to the SPT, presented a 
statistically significant higher number of sites that required additional surgical 
and/or antibiotic treatment. Therefore, patients should be informed, from the 
beginning, of the value of the SPT in enhancing long-term outcomes of 
implant therapy, particularly those affected by periodontitis.
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Introduction 
The use of dental implants for replacement of missing teeth has become a 
routine procedure also in the rehabilitation of the periodontally compromised 
patients (PCP), even though several studies have identified a high prevalence 
of  peri-implantitis  (Berglundh et al. 2002; Fransson  et al.  2005;  Ferreira et 
al. 2006; Roos-Jansker et al. 2006; Kolds- land et al. 2010; Simonis et al. 
2010; Rinke et al.  2011;  Costa   et al.   2012;   Marrone et al. 2012). In our 
previous publications (Roccuzzo et al. 2010, 2012), the implant 10-year 
survival rate varied from 98% in periodontally healthy subjects (PHP) to 90% 
in severe PCP, even though the lack of adhesion to supportive periodontal 
therapy (SPT) was associated with a higher incidence of biological 
complications and a greater need for further therapy. These results were 
based on the analysis of 112 patients treated, during the years 1996-1999, by 
means of implants with a coated, titanium plasma-sprayed surface (TPS), 
which was rather rough and micro- porous and not commercially available 
nowadays. At the end of the 1990s, implants with the same geometry, but with 
a sand- blasted and acid-etched (SLA) surface, were introduced to the market 
to allow loading, in standard bone conditions, after 6 weeks. It seemed 
natural, at that point, to  perpetuate the long-term analysis on another group 
of patients with a similar protocol, around implants with the new surface. 
The aim of this study was to prospectively assess the 10-year results of 
therapy by means of SLA implants in a group of PHP compared with a group 
of PCP of both moderate and severe grade. The outcomes regarding implant 
loss, bone loss, soft tissue recessions, pus, deep pockets, plaque and 
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bleeding on probing around implants, the additional treatments and number of 
teeth lost in these patients are described in this article. 
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Material and methods 
Study population 
All patients attending the principle investigator (M.R.), a specialist in 
periodontology, for dental implant therapy between December 1998 and 
September 2001 were screened for possible inclusion in the study. 
Exclusion criteria were:  
• complete edentulism;  
• presence of an implant-supported overdenture;  
• mucosal diseases;  
• alcohol and drug abuse;  
• pregnancy;  
• uncontrolled metabolic disorders;  
• aggressive periodontitis;  
• no interest in participating in the study.  
Patients were informed that their data would be used for statistical analysis 
and gave their informed consent to the treatment. No ethical committee 
approval was sought to start this study, as it was not required by national law 
or by ordinance of the local inspective authority. The prospective study was 
performed in accordance with the principles stated in the Declaration of 
Helsinki and the Good Clinical Practice Guidelines. 
Pre-treatment clinical examination 
Gender, date of birth, smoking habits, medical history at the time of the initial 
visit and treatment planning were obtained. Moreover, subjects were clinically 
and radiographically monitored at baseline. Full mouth plaque score (FMPS), 
full mouth bleeding score (FMBS) and pocket depth (PD) were measured at 4 
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sites per tooth for all teeth by means of a periodontal probe (XP23/UNC 15, 
Hu-Friedy, Chicago, USA), and rounded off to the nearest millimeter. 
At the baseline, 3 groups were formed on the basis of the clinical diagnosis. 
Patient without sign of periodontitis were classified as PHP (periodontally 
healthy patients). Patient with an initial diagnosis of periodontitis (PCP) 
received a score (S) on the basis of the number and depth of periodontal 
pockets according to the following formula: 
S = Number of pockets (5-7mm) + 2 Number of pockets (>8 mm).   
These patients were further divided in 2 groups: 
• Moderate PCP: periodontally compromised patients with S < 25 
• Severe PCP:  periodontally compromised patients with S > 25. 
Periodontal therapy  
Following selection, all patients received appropriate initial therapy, 
consisting, depending on the cases, in motivation, oral hygiene instruction and 
scaling and root planning. Hopeless teeth were recorded and extracted. 
Periodontal surgery was performed as needed after re-evaluation. Guided 
tissue regeneration was pursued, when feasible. Individual treatment was 
thoroughly discussed with the patients and established according to their 
personal need and desire. No implant surgery was performed before the 
assurance of excellent motivation and compliance from each single patient 
(FMPS≤15%; FMBS≤15%). 
Implant placement and prosthetic reconstruction 
Sandblasted and acid-etched (SLA) dental implants (Institut Straumann AG, 
Walden- burg, Switzerland) were placed, under local anesthesia, by the same 
operator (MR), according to the manufacturer’s instructions. Full-body screws 
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were used, 8, 10 and 12 mm long, 3.3, 4.1 and 4.8 mm in diameter. All 
implants were placed using a standardized surgical procedure (Buser et al. 
2000). The implants were placed with the border of the rough surface  
approximating the alveolar bone crest leaving the machined neck portion in 
the transmucosal area. Implants  that  required  bone  augmentation and/or 
sinus lift elevation were not included in the study. If necessary, an excision of 
soft tissue was performed to allow a close adaptation of the wound margins to 
the implant shoulder without submerging it. The number, position and type of 
implants in each patient were determined after a thorough diagnosis of the 
anticipated needs for the planned prosthesis and the presence of anatomical 
limitations. 
Appropriate healing screws were placed on top of the implants and the flaps 
were sutured, in a non-submerged fashion. Abutment connection was carried 
out 6–12 weeks after implant surgery by the same operator. Abutments for 
cemented restoration were selected according to the  intermaxillary space. All 
patients were provided with implant-supported fixed restorations. All 
restorations were fabricated to facilitate both the oral hygiene procedures and 
the probing along their circumference. Baseline probing measurements were 
also recorded around the implants. Radiographic data were collected, after 
prosthesis installation, to establish a baseline reference for the following 
controls. 
Follow- up 
Patients were placed on an individually tailored maintenance care program 
(SPT), including continuous evaluation of the occurrence and the risk of 
disease progression. Motivation, re-instruction, instrumentation and  treatment  
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of  re-infected  sites were performed as needed. If a patient expressed the 
desire not to attend follow-up examinations, he/she was classified as 
“dropout”. The diagnosis and treatment of peri-implant biological 
complications were performed according to cumulative interceptive supportive 
therapy (CIST) (Mombelli & Lang 1998), which consists in a series of 
treatment procedures that have to be cumulative adopted, from A  to  E,  
depending on the health conditions of the peri-implant tissues: (A) mechanical 
cleansing and improvement in patient’s oral hygiene, consisting in removal of 
hard deposits with soft scalers, polishing with rubber cup and paste. 
Instruction for more effective oral hygiene practices; (B) antiseptic therapy  
with chlorhexidine  digluconate  or  local  application of chlorhexidine gel; (C) 
systemic antibiotic therapy or treatment with local delivery device; (D) surgical 
therapy; and (E) explantation. The number of sites treated according to 
therapy modalities C and D (antibiotics   and/or   surgery) during the 10 years 
was also registered.  
Final clinical examination 
After 10 years, two calibrated examiners, blinded to the initial classification of 
the patients, recorded, for each test implant, probing depth (PD) measured at 
four sites (mesial, buccal, distal and lingual) by means of a periodontal probe 
(XP23/UNC 15,  Hu-Friedy, Chicago, USA), and rounded off to the nearest 
millimeter.   
At the same time the following parameters were collected:  
• Implant loss: the time in months for any implant lost; 
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• plaque score (presence/absence): total score for both teeth and implants 
(FMPS) and for implants alone (Pl), measured at four sites per tooth and 
implant and expressed as a percentage of examined sites; 
• bleeding on probing score (presence/absence): total score for both teeth 
and implants (FMBS) and for implants alone (BOP), measured at four sites 
per tooth and implant and expressed as a percentage of examined sites; 
• smoking habits; 
• number of missing teeth at baseline; 
• number of extracted  teeth during (APT); 
• number of lost teeth during SPT; 
• complete adhesion to the SPT (yes or no);  
• deepest PD during the SPT;  
• deepest PD at 10-year follow-up; 
• number of patients, who required, during the SPT, either C or D therapy 
modality. 
Statistical analysis 
Data were expressed as mean±SD and median (interquartile range) or counts 
and percentages.  
The statistical distribution of all, except age, quantitative parameters was 
found to be non-Gaussian (tested by Shapiro–Wilk test), and the significance 
of between-group differences of the skewed quantitative measures was 
assessed by generalized linear model (GLM) with gamma parameterization. 
Logistic regression models by GLM with logit link and binomial variance 
function were used to analyze categorical variables. 
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Because patients received more than one implant, standard errors were all 
estimated taking account of the correlation of observations. Pairwise 
comparisons of adjusted predictions between the three groups were 
performed using Bonferroni’s adjustment for multiple comparisons, and a p < 
0.016 was considered significant. Due to a significant difference between the 
three groups analyzed, each model was adjusted for patient’s age. 
All the tests were two-tailed, and statistical significance level was set at 0.05. 
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Results 
Patient population 
Of the initial 149 patients enrolled in the study, 26 patients (51 implants) were 
lost to follow up: 5 died, 3 and 2 patients, respectively, were not able to attend 
the final examination due to severe health problems or because they moved, 
and 16 refused the follow-up visit (Table 1). 
The final analysis was performed on 123 subjects: 32 PHP, 46 moderate PCP 
and 45 severe PCP, corresponding to 54,96 and 102 implants, respectively. 
PHP had a statistically significant lower mean age (43.3 ± 12.4 years) 
compared with both moderate (53.3 ± 10.7) and severe PCP (52.7 ± 8.4). The 
mean number of pockets both 5–7 mm and ≥ 8 mm at baseline was 
statistically significantly different (p < 0.0001) between the three groups (Table 
2). 
Periodontally healthy patients (PHP) had and lost less teeth, at the baseline 
and during the active therapy, respectively, compared with both PCP groups. 
The mean number of teeth lost during the SPT was 0.7 ± 1.0 for PHP, 1.3 ± 
1.3 for moderate and 1.9 ± 1.9 for severe, respectively, with a significant 
difference among the three groups (p < 0.0001; Table 2). 
At baseline, statistically significant differences were found among the three 
groups regarding both FMPS and FMBS (Table 3). Both parameters  
increased  from   PHP (29.0 ± 9.2 and 25.0 ± 11.8) to moderate PCP (37.9 ± 
9.3  and  36.9 ± 12.7)  up  to  severe PCP (51.6 ± 22.4 and 48.9 ± 19.4). 
At the 10-year examination, both FMPS and FMBS decreased in all groups 
and the differences between the groups were not statistically significant. 
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Implant survival rate 
In PHP, no implant loss occurred, yielding a survival rate of 100% at 10-year 
follow-up. Three implants in each PCP group were lost, with a survival rate of 
96.9% and 97.1% in moderate PCP and severe PCP, respectively. 
Considering only the patients who adhered to SPT, the survival rate was 
100% for moderate PCP and 98.6% for severe PCP. These values decreased 
to 93.2% and 93.3% for moderate and severe PCP, who did not fully adhere 
to SPT. Differences between the groups were not statistically significant 
(Table 4). 
PD and radiographic bone loss 
During SPT, 6 implants in PHP, 24 in moderate and 36 in severe PCP 
presented at least one site with probing depth ≥ 6 mm. The differences were 
significant between the PHP and both PCP groups (Table 4). No radiographic 
bone loss ≥ 3 mm was recorded for implants in PHP. On the contrary, 9.4% 
and 10.8% of the implant surfaces displayed a radiographic bone loss ≥ 3 
mm, respectively, in moderate and in severe PCP. The differences between 
PHP and both PCP groups were statistically significant (p < 0.001; Table 4). 
Pus and interventions C or D during the SPT  
During the 10-year period, pus was detected around 11 of 93 implants in 
moderate PCP, 8 of 99 implants in severe PCP, while it was never found in  
PHP. The difference between PHP and both moderate (p = 0.002) and severe 
PCP (P = 0.01) was statistically significant (Table 5). 
Periodontally healthy patients (PHP) needed in 18.8% of the cases an 
antibiotic or surgical therapy for the treatment of biological complications 
(Table 4). The corresponding values for moderate and severe PCP were 
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52.2% and 66.7%, respectively. The statistical analysis revealed a significant 
difference between PHP and both PCP groups (PHP vs. moderate PCP: p = 
0.001; PHP vs. severe PCP: p < 0.001). 
Clinical parameters at the 10-year follow-up  
PIaque around the tested implants was found at  the 10-year examination as   
follows: 19.9 ± 21.9% for PHP, 34.7 ± 33.6% for moderate PCP and 33.3% ± 
28.1% for severe PCP, while BoP was found to be 31.9 ± 26.3%, 34.7 ± 
33.0% and 38.4 ± 28.6%, respectively (Table 5). A few implants (4 vs. 7 vs. 8) 
displayed a  mucosal recession ≥ 3 mm at the 10-year examination with no 
significant difference among the groups (p = 0.99). 
SPT 
Thirteen PHP, 21 moderate PCP and 14 severe PCP had an inconsistent 
attendance to the SPT or refused the proposed additional treatment, during 
the 10-year period. These subgroups of patients showed worst results in 
terms of PI, BoP, mean PD, number of teeth lost during SPT, mean deepest 
PD at the 10-year examination, as well as mean deepest PD registered during 
the follow-up (Tables 6 and 7). 
The differences between patients adhering or not to the SPT were statistically 
significant in the following cases: 
• moderate PCP: PI (p < 0.001), BoP (p = 0.018), deepest PD at 10-year (p 
= 0.02) and implants with at least one site with PD ≥ 6 mm (p < 0.001); 
• severe PCP: probing depth (p = 0.03), teeth lost during SPT (p = 0.03), 
deepest PD at 10 year (p = 0.01) and implants with at least one site with 
PD ≥ 6 mm (p = 0.001). 
No significant difference was found among the PHP group. 
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Patients regularly attending to the SPT received a greater number of C or D 
interventions during the follow-up compared with the ones who did not.  
However, these differences were not statistically significant. 
Considering FMPS and FMBS, the analysis revealed a trend to higher values, 
both at baseline and at final examination, for patients inconsistently attending 
SPT compared with regular attendees. The differences were highly significant 
for moderate and severe PCP (Table 8). 
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Discussion 
Long-term results of implant therapy in patients with a history of periodontitis 
have received significant attention in the last years. Since the publication of 
the second part of the previous study (Roccuzzo et al. 2012), several studies, 
many of them retrospective or cross-sectional, have been published on this 
topic. 
Rinke et al. (2011) evaluated the prevalence rates of  peri-implant mucositis  
and peri-implantitis in 89 partially edentulous patients in a private practice-
based cross-sectional study. In this study, periodontal disease could not be 
determined as a risk factor for peri- implant mucositis and/or peri-implantitis. 
In their discussion, the authors tried to explain the reasons why the study 
failed to determine history of periodontal disease as a risk indicator for peri-
implant diseases, as it included only patients with chronic periodontitis. It 
appears plausible that patients with aggressive periodontitis are likely to  
exhibit a higher risk of peri-implant diseases. It must be said, however, that an 
unequivocal distinction between severe and aggressive periodontitis is very 
difficult in the clinical practice (Picolos et al. 2005), and it is one of the reasons 
why it was not applied in our protocol. Nevertheless, the authors concluded 
that smoking and compliance were important risk factors for peri-implant 
inflammations in partially edentulous patients. These results are in 
concordance with another recent long-term study (Aglietta et al. 2011). In the 
present study, the relative number of smokers (21 of 123) was limited and did 
not allow any statistical analysis. 
Around the same time, Levin et al. (2011) published a prospective cohort 
study consisting of 736 patients (2336 implants) with a follow-up to 144 
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months (mean 54.4 months). The Kaplan–Meier estimates for the cumulative 
survival rate (CSR) at 108 months were 0.96 and 0.95 for implants inserted 
into healthy and moderate PCP, respectively. The CSR declined to 0.88 at 
108 months for the severe PCP. The extended Cox model revealed that until 
around 50 months, periodontal status is not a significant factor but after 50 
months, the hazard for implant failure is eight times greater for the severe 
PCP. These results are in accordance with our previous publications 
(Roccuzzo et al. 2010, 2012) but they could not be confirmed in this last 
research. The reason for this is not fully understood. It must be said, however,  
that both the stricter selection criteria  regarding the presence of inflammation 
and the additional treatment during SPT have significantly reduced the 
number of implant loss, thus limiting the possibility to determinate the 
influence of the initial periodontal diagnosis on implant survival. 
Ormianer & Patel (2012) have published a retrospective study on the efficacy 
of dental implant therapy in PCP, monitored annually for at least 9.5 years. 
They found that periodontal susceptibility resulted in increased bone loss but 
did not affect implant survival. This is partially in accordance with the results 
of this study, where no sites presented bone loss ≥ 3 mm in PHP, 9.4% in 
moderate PCP and 10.8% in severe PCP, with a significant difference among 
PHP and both PCP groups. 
The fact that no radiographic bone loss ≥ 3 mm was recorded for implants in 
PHP confirms that proper placement in healthy patients, who are enrolled in a 
proper maintenance program, has an extremely low incidence of biological 
complications around SLA implants. Similar results were recently published by 
Buser et al. (2012) who presented a retrospective analysis resulted in a 10-
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year implant survival rate of 98.8% and a success rate of 97.0%. In addition, 
the prevalence of peri-implantitis in this large cohort of orally healthy patients, 
treated by means of the same implant type, was low with 1.8% during the 10-
year period. The possibility to have the same results with other implant types 
and surfaces cannot be confirmed at the present time. There is the definitive 
need for long-term prospective observational studies for the different fixtures 
as results cannot be transferred from one system to another one, as 
advocated by a recent systematic review (Safii et al. 2010). 
There are opinions among clinicians that the prognosis of complex periodontal 
therapy may not match the high levels of success of treatment with implants. 
As a consequence, more and more teeth are extracted on the assumptions 
that  implants  perform  better than periodontally compromised teeth and that 
their longevity is independent of the individual’s susceptibility to periodontitis 
(Lundgren et al. 2008). In reality, during the 10-year SPT, the mean number of 
teeth lost per patient, regardless of the clinician providing the service and the 
reason for the extraction, was 0.7 ± 1.0 for PHP, 1.3 ± 1.3 for moderate PCP 
and 1.9 ± 1.9 for severe PCP, with a significant difference between PHP and 
PCP. It is important to note that in relation to the adhesion to the SPT, no 
difference was found for PHP, a limited, but not significant difference was 
found in the moderate PCP (1.6 ± 1.4 vs. 1.1 ± 1.2), while a significant 
difference was found for severe PCP (2.9 ± 2.3 vs. 1.4 ± 1.5). These results 
confirm that PCP, who are not completely enrolled in an appropriate SPT, 
tend to have more complications both around implants and teeth and should 
not be treated on the assumption that the implants perform better than teeth. 
These conclusions are similar to those reported by Pjetursson et al. (2012) in 
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70 patients with a follow-up ranging from 3 to 23 years (mean 7.9 years). After 
installation of the implants, 58 patients entered a university SPT program and 
12 had SPT in a private practice. The authors reported that the prevalence of 
peri-implantitis was lower in the group followed in a well-organized SPT at the 
university. The present paper, on the contrary, presents excellent results in 
terms of overall compliance even for patients in a private office. 
Mir-Mari et al. (2012) estimated the prevalence of peri-implantitis in private 
practice patients, enrolled in a periodontal maintenance program, between 
12% and 22%, similarly to those published in university environment samples. 
Nevertheless, it must be stressed, once again, the importance of SPT 
regardless of the fact that it takes place in a public or private base. In the 
present study, 26 of 149 (17.4%) patients were lost to follow up and only 16 of 
these (10.7%) refused the visit for various personal reasons. These values 
should be considered positively in consideration of the long period of the 
follow-up, and they are somehow similar to those published in a recent paper 
reporting results in a private practice by Cardaropoli & Gaveglio (2012). 
The overall quality of the SPT in the present research can be confirmed by the 
significant reduction in the FMPS and FMBS values at the 10-year follow-up. 
These changes are more pronounced in patients adhering to SPT comparing 
to the ones not adhering to SPT. Indeed, patients undergoing a successful 
SPT should have similar low plaque scores regardless of the history for 
periodontitis. In this group of patients, the FMPS, at the 10- year evaluation, 
before the session of scaling, was below the 25% threshold, that is, 
respectively, 19.0 ± 10.4% vs. 23.4 ± 15.3% vs. 22.9 ± 14.4%, with no 
difference among the groups. 
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The  number  of  implants  with  a  PD≥ 6 mm varied among the three groups, 
with differences that were statistically significant (Table 4).  Our data  support  
the need for a SPT where clinical and, when indicated, radiographic 
parameters should be re-assessed at every follow-up visit to detect peri-
implant infections as earlier as possible and to intercept the problems with 
appropriate therapy (Mombelli & Lang 1998). 
During the entire period of observation, six implants were removed for 
biological complications in PCP. It must be noted that these results are better 
than those published in a different group of patients treated with TPS implants 
(Roccuzzo et al. 2010, 2012). While the TPS surface has Sa values of 
approximately 3.1 lm, SLA has Sa values of approximately 2.0 lm (Buser et al. 
1999). The lower microroughness should be particularly important in PCP, 
because it is suggested that peri-implantitis is influenced by surface 
characteristics (Berglundh et al. 2007; Albouy et al. 2008, 2009). However, 
caution is needed comparing the present study with the previous ones 
(Roccuzzo et al. 2010, 2012), because of stricter plaque regimen entry level 
(FMPS ≤ 15% vs. FMPS ≤ 25%). 
The results of the present investigation do not confirm the observation by 
Charalampakis et al. (2012) who found, in a retrospective study, that SLA was 
statistically significantly associated with peri-implantitis, while TPS was not. It 
must be said, however, that in a recent systematic review, prepared for the 
Seventh European Workshop on Periodontology, Renvert et al. (2011) 
revealed that only few studies provided data on how implant surfaces 
influence peri-implant disease, with no evidence that implant surface 
characteristics can have a significant effect on the initiation of peri-implantitis. 
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There is no reason to assume that the shorter waiting time between surgery 
and loading in this group of patients (6–12 weeks) compared with the previous 
one (3–6 months) (Roccuzzo et al. 2010) had any significant effect of the 
overall results, but this cannot be confirmed. 
Finally, antibiotic and/or surgical therapy was performed in 18.8% of cases in 
PHP, in 52.2% of cases in moderate PCP and in 66.7% cases in severe  
PCP. In  other  words, in order to have a very elevated long-term survival rate, 
it is mandatory  to  monitor patients frequently, especially those who lost teeth 
due to periodontal disease, to organize and to promptly carry out adjunctive 
additional treatment, as needed. Therefore, implant therapy cannot be simply  
proposed as “definitive”, but it should be considered only as an important step 
in the comprehensive long-term treatment plan of patients. 
In conclusion: 
• Overall, proper therapy by means of SLA implants, supporting  both 
single  crowns and fixed dental prostheses, offers predictable long-term 
results. 
• In particular, healthy patients who are enrolled in a proper maintenance 
program have an extremely low incidence of biological complications. 
• Patients with a history of periodontitis should be informed that they are at 
higher risk of peri-implant disease. 
• Excellent values of  long-term survival rate can be obtained even in PCP, 
if these are placed on an individually tailored maintenance care program, 
including continuous evaluation of the occurrence and the risk of disease 
progression. 
• PCP, even though achieved optimal plaque control, may need further 
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therapy to limit the nature and extent of biological complications 
throughout time. 
• Biological complications, detected at an early stage, can be successfully 
treated by means of antibiotics and/or regenerative surgery in a high 
percentage of cases. 
• Regardless of their initial status, patients may experience peri-implant soft 
tissue dehiscence, which may cause esthetic problems. 
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Table 1.  Number of patients and implants lost to the 10-year follow-up. 
 
 Patients Implants Reason for drop-out 
 5 13 Death 
 3 8 Severe health problems 
 2 3 Moved 
 16 27 Refused to accept a visit 
Total  26 51  
 
Table 2.   Study population: total number of patients attending the 10-year examination, mean age and number of smokers. Mean number of 
teeth missing at baseline, extracted during Active Periodontal Therapy (APT) and during SPT. 
 
 
Patients at 
the 10-year 
examination 
Mean age 
(years) Smokers 
Number of 
pockets 
5-7 mm 
Number of 
pockets 
≥ 8 mm 
Teeth 
missing at 
baseline 
Teeth  
extracted 
during APT 
Teeth  
lost during 
SPT 
PHP 32 
 
43.3 ± 12.4 
 
5 
 
0.9 ± 1.0 
1 (0-1.5) 
 
0 
0 (-) 
 
3.2 ± 3.1 
2 (1-4.5) 
 
1.3 ± 1.2 
1 (1-2) 
 
0.7 ± 1.0 
0 (0-1) 
Moderate PCP 46 
 
53.3 ± 10.7 
 
6 
 
7.5 ± 3.4 
7 (6-8) 
 
2.7 ± 1.9 
2.5 (1-4) 
 
7.1 ± 4.6 
7 (3-10) 
 
2.3 ± 1.9 
2 (1-3) 
 
1.3 ± 1.3 
1 (0-2) 
Severe PCP 45 
 
52.7 ± 8.4 
 
10 
 
23.3 ± 10.0 
21 (15-27) 
 
 
8.6 ± 5.9 
7 (5-10) 
 
  5.6 ± 3.8 
5 (2-8) 
   3.5 ± 2.8 
3 (1-4) 
1.9 ± 1.9 
1 (1-3) 
 
Statistical difference between: 
All groups 
PHP and moderate PCP 
PHP and severe PCP 
Moderate PCP and severe PCP 
 
 
 
 
   p < 0.0001 
p = 0.01 
p = 0.99 
 
 
p = 0.49 
 
 
 
p < 0.0001 
p < 0.0001 
p < 0.0001 
 
 
 
 
p < 0.0001 
p < 0.0001 
p < 0.0001 
 
 
 
p=0.05 
 
 
 
p<0.02 
 
 
 
 
p < 0.0001 
p < 0.0001 
p < 0.0001 
 
 
  
 27 
 
Table 3. Patients' compliance and clinical parameters (Full-mouth plaque score [FMPS] and full-mouth bleeding score [FMBS]) at baseline and 
at the 10-year follow-up. 
 
 
Patients at 
the 10-year 
examination 
Patients 
adhering /  
not adhering 
to SPT 
FMPS 
baseline 
FMBS 
baseline 
FMPS 
at 10-year 
follow-up 
FMBS 
at 10-year 
follow-up 
PHP 32 
 
19 / 13 
 
29.0 ± 9.2 
30 (22-34) 
 
25.0 ± 11.8 
25 (18-30) 
 
22.1 ± 10.8 
22 (13-30) 
 
18.4 ± 12.6 
15 (10-25) 
Moderate PCP 46 
 
25 / 21 
 
37.9 ± 9.3 
35 (30-45) 
 
 36.9 ± 12.7 
  33 (28-45) 
 
27.7 ± 14.8 
25 (16-33) 
 
25.2 ± 13.0 
23 (16-32) 
Severe PCP 45 
 
31 / 14 
 
51.6 ± 22.4 
45 (35-70) 
 
 48.9 ± 19.4 
45 (35-60) 
  
30.4 ± 20.6 
25 (15-38) 
 
27.4 ± 19.0 
22 (19-32) 
 
Statistical difference between: 
All groups 
PHP and moderate PCP 
PHP and severe PCP 
Moderate PCP and severe PCP 
 
 
 
p = 0.36 
 
 
 
p = 0.001 
p < 0.0001 
p < 0.0001 
 
 
 
p =0.001 
p < 0.0001 
p = 0.001 
 
 
 
p=0.22 
 
 
 
p=0.02 
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Table 4. Implants placed, implants lost, survival rates, number of implants with deepest PD > 6mm, percentage of sites with bone loss ≥ 3 mm 
and percentage of patients treated with cumulative interceptive supportive therapy (CIST) C/D, during the 10-year supportive periodontal therapy 
(SPT) 
 
  
 Implants  placed 
Implants 
lost  
Survival Rate (%) 
Implants  
with deepest 
PD > 6mm  
Radiographic 
bone loss  
≥ 3 mm (%) 
 
 
Patients 
treated with 
CIST C/D (%) All 
patients 
Patients 
adhering  
to SPT 
Patients not 
adhering  
to SPT 
PHP 54 0 
100 100 100 
6 0 18.8 
Moderate PCP 96 3 
96.9 100 93.2 
24 9.4 52.2 
Severe PCP 102 3 
97.1 98.6 93.3 
36 10.8 66.7 
Statistical difference between: 
 
All groups 
 
PHP and moderate PCP 
PHP and severe PCP 
Moderate PCP and severe PCP 
  
 
 
 
p = 0.65 
 
 
 
p = 0.95 
 
 
p = 0.62 
 
 
 
 
p = 0.015 
  p <0.001 
  p = 0.65 
 
 
p <0.001 
 
p<0.001 
p<0.001 
p=0.97 
 
 
 
 
  p = 0.001 
       p < 0.001 
   p = 0.95 
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Table 5. PI and BoP around the implants at the 10-year examination.  
 
 Patients at 
the 10-year 
examination  
Implants 
available 
at 10y 
PI around 
implants 
(%) 
BoP around 
implants 
(%) 
Implants 
with pus 
during SPT 
Deepest PD 
(mm) 
 during SPT  
Implants with 
REC ≥3mm 
during SPT 
PHP 32 54 
 
19.9 ± 21.9 
25 (0-25) 
 
31.9 ± 26.3 
25 (0-50) 
 
0 
 
4.4 ± 1.1 
4 (4-5) 
 
4 
Moderate PCP 46 93 
 
34.7 ± 33.6 
25 (0-50) 
 
34.7 ± 33.0 
25 (0-50) 
 
11 
 
4.6 ± 1.3 
4(4-5) 
 
7 
Severe PCP 45 99 
 
33.3 ± 28.1 
25 (0-50) 
 
38.4 ± 28.6 
25 (0-50) 
 
8 
 
4.8 ± 1.4 
4 (4-5) 
 
8 
 
Statistical difference between: 
All groups 
PHP and moderate PCP 
PHP and severe PCP 
Moderate PCP and severe PCP 
   
 
p=0.05 
 
 
 
p=0.49 
 
 
 
  p = 0.002 
p = 0.01 
p = 0.98 
 
 
p = 0.16 
 
 
p = 0.99 
Number of implants with pus, deepest PD and number of implants with mucosal recession (REC) ≥ 3 mm during the supportive 
periodontal therapy (SPT) 
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Table 6. Clinical parameters around the implants at the 10-year follow-up in relation to adhesion to supportive periodontal therapy (SPT) in the 
three groups. 
 
  
 
Adhesion  
to SPT 
Number of 
patients 
Pl  
(%) 
BOP  
(%) 
PD 
(mm) 
Teeth lost  
during SPT 
PHP 
No 13 
 
22.7 ± 24.3 
25 (0-25) 
 
38.7 ± 31.6 
37 (0-35) 
 
3.7 ± 0.8 
  4 (3.5-4.3) 
 
0.7 ± 1.2 
0 (0-1) 
Yes 19 
 
18.0 ± 20.0 
25 (0-25) 
 
27.3 ± 21.4 
25 (0-50) 
 
3.4 ± 0.6 
  3.3 (3-3.8) 
 
0.7 ± 0.9 
0 (0-1) 
p-value         p = 0.54 p = 0.21 p = 0.22 p = 0.98 
Moderate PCP 
No 21 
 
50.6 ± 31.9 
50 (25-75) 
 
47.0 ± 36.3 
50 (25-75) 
 
4.2 ± 1.3 
4 (3-5) 
 
1.6 ± 1.4 
1 (0-3) 
Yes 25 
 
22.1 ± 29.6 
0 (0-25) 
 
25.0 ± 26.7 
25 (0-50) 
 
3.4 ± 0.8 
     3.3 (2.7-4.1) 
 
1.1 ± 1.2 
1 (0-2) 
p-value   p < 0.001 p = 0.018 p = 0.05 p = 0.47 
Severe PCP 
No 14 
 
44.6 ± 30.7 
50 (25-50) 
 
46.4 ± 30.2 
50 (25-75) 
 
4.4 ± 1.1 
4.4 (4-5.2) 
 
2.9 ± 2.3 
2.5 (1-4) 
Yes 31 
 
28.9 ± 25.9 
25 (0-50) 
35.2 ± 27.6 
25 (25-50) 
3.8 ± 0.9 
3.6 (3.3-4.3) 
1.4 ± 1.5 
1 (0-2) 
p-value   p = 0.06 p = 0.12 p = 0.03 p = 0.03 
Pl, presence of dental plaque; BoP,bleeding on probing; PD, probing depth 
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Table 7. Number of patients treated with cumulative interceptive supportive therapy (CIST) C/D, deepest PD around implants and percentage of 
implants with deepest PD > 6mm in relation to adhesion to supportive periodontal therapy (SPT) in the three groups. 
 
Adhesion  
to SPT 
 
Number of 
patients 
N. of patients 
treated with 
CIST C/D 
Mean 
deepest PD 
at 10–year  
(mm) 
Implants with 
at least a site 
with PD>6mm 
at 10-year  
PHP 
No 13 2 
 
4.8 ± 1.3 
5 (4-5) 
 
4 / 22 
Yes 19 4 4.2 ± 0.9 4 (4-5) 2 / 32 
p-value   p = 0.99 p = 0.25 p = 0.21 
Moderate PCP 
No 21 11 
 
5.1 ± 1.4 
5 (4-6) 
 
20 / 44 
Yes 25 13 4.2 ± 1.1 4 (3-5) 4 / 52 
p-value   p = 0.98 p = 0.02 p < 0.001 
Severe PCP 
No 14 10 
 
5.4 ± 1.5 
6 (4-6) 
 
18 / 30 
Yes 31 20 4.6 ± 1.3 5 (4-5) 18 / 72 
p-value   p = 0.65 p = 0.01 p = 0.001 
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Table 8.  Full-mouth plaque score (FMPS) and full-mouth bleeding score (FMBS) at baseline and at follow-up in patients adhering and not 
adhering to supportive periodontal therapy (SPT). 
 
 
Adhesion  
to SPT 
 
Number of 
patients 
 
FMPS 
baseline 
FMBS 
baseline 
FMPS 
at 10-year 
follow-up 
FMBS 
at 10-year 
follow-up 
PHP 
No 13 
 
31.1 ± 10.3 
30 (29-40) 
 
 
27.5 ± 15.2 
25 (18-35) 
 
 
26.5 ± 10.2 
25 (22-30) 
 
 
22.2 ±14.8 
20 (15-26) 
 
Yes 19 27.6 ± 8.3 29 (20-33) 
23.4 ± 8.8 
25 (18-28) 
19.0 ± 10.4 
15 (10-25) 
15.8 ± 10.5 
12 (8-22) 
p-value   p = 0.23 p = 0.26 p = 0.04 p = 0.30 
Moderate PCP 
No 21 
 
42.6 ± 8.9 
 44 (35-45) 
 
44.5 ± 12.9 
40 (35-50) 
32.7 ± 12.8 
    30 (25-40) 
31.2 ± 13.1 
30 (20-36) 
Yes 25 34.0 ± 7.7 33 (30-36) 
30.4 ± 8.3 
30 (26-32) 
23.4 ± 15.3 
20 (12-30) 
20.1 ± 10.8 
20 (12-25) 
p-value   p < 0.0001 p < 0.0001 p = 0.005 p = 0.001 
Severe PCP 
No 14 
 
60.7 ± 18.1 
66 (45-77) 
 
56.2 ± 18.0 
57 (45-60) 
46.9 ± 23.2 
44 (30-55) 
43.2 ± 25.6 
41 (22-50) 
Yes 31 47.4 ± 23.1    42 (33-70) 
45.6 ± 19.4 
40 (30-61) 
22.9 ± 14.4 
20 (15-28) 
20.3 ± 8.6 
20 (15-25) 
p-value   p = 0.01 p = 0.04 p = 0.001 p = 0.001 
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